Mankind Pharma

company

About

Mankind Pharma is a pharmaceutical company that develops, commercializes, and delivers medicines for urgent medical needs.

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$24M
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 1995
Number Of Employee
10001 - max
Operating Status
Active
Legal Name
MANKIND PHARMA LTD.

Mankind Pharma aspires to aid the community in a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. Mankind Pharma came into existence in 1986, and in 1991, the company was formed into a legal corporation. However, it actively started working as a fully-integrated pharmaceutical company in 1995. Today, Mankind has an employee base of over 14,000 and is racing towards $1 Billion.

The company takes great pride in the success of its products ranging from Pharma, OTC, and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Adiction, Gas-O-Fast, Kaloree 1 and many others.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$239M
Mankind Pharma has raised a total of $239M in funding over 2 rounds. Their latest funding was raised on May 28, 2015 from a Secondary Market round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 28, 2015 Secondary Market $215M 1 Capital Group Detail
Apr 30, 2007 Private Equity(PE) $24M 2 Chrys Capital Detail

Investments

Number of Investments
Number of Lead Investments
8
2
Mankind Pharma has made 8 investments. Their most recent investment was on Jun 23, 2022, when BatX Energies raised ₹130M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 23, 2022 BatX Energies
Seed ₹130M Energy
Mar 21, 2022 Leverage Edu
Series B $22M Artificial Intelligence
Jan 19, 2022 Dogsee Chew
Series A ₹500M Food and Beverage Yes
Aug 11, 2021 Miko
Series B ₹2.13B Artificial Intelligence Yes
Jun 9, 2021 Eight Sleep
Angel Consumer Electronics

Investors

Number of Lead Investors
Number of Investors
2
3
Mankind Pharma is funded by 3 investors. Capital Group and Chrys Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Capital Group Yes Secondary Market
Chrys Capital Yes Private Equity(PE)
HarbourVest Partners Private Equity(PE)

Employee Profiles

Number of Employee Profiles
6
Mankind Pharma has 6 current employee profiles, including Executive Rajeev Juneja
Executive
Employee
Executive
Employee
Executive

Acquisition

Mankind Pharma has acquired 2 organizations. Their most recent acquisition was Panacea Biotec Pharma - Formulations business on Feb 1, 2022. They acquired Panacea Biotec Pharma - Formulations business for ₹19.08B.

Date Company Name
Industry Acquisition Type Price
Biopharma acquisition ₹ 19.08B Detail
Health Care acquisition Detail